Nyu Langone Health

New York, New York 330306

322 studies enrolling now · 809 studies all time

What they study most

1st Line NSCLC, ACL Injury, ACL Reconstruction, ACL Reconstruction (ACLR) With a Bone-patellar Tendon-bone (BPTB) Autograft, ADHD, ALK-positive Non-small Cell Lung Cancer (NSCLC), ALS (Amyotrophic Lateral Sclerosis), ASD, AVB - Atrioventricular Block, Ablation, Achilles Injuries Tendon, Acute Decompensated Heart Failure

Studies at this site

• Treatment of Antibody-Mediated Rejection (ABMR) With CarBel — Recruiting now
• Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy — Recruiting now
• The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms — Recruiting now
• Neurobehavioral Mechanisms of Psilocybin-assisted Treatment for AUD — Recruiting now
• Young Onset Parkinson's Disease Subtypes and Pathogenic Mechanisms — Recruiting now
• Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma — Recruiting now
• Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission — Recruiting now
• A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II) — Recruiting now
• Prospective Database of Clinical Outcomes Following Cryotherapy for Ablation of Clinically Localized Prostate Cancer — Recruiting now
• Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions — Recruiting now
• A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases — Recruiting now
• RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses — Recruiting now
• A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin — Recruiting now
• A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) — Recruiting now
• Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer — Recruiting now
• A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure — Recruiting now
• Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease — Recruiting now
• IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) — Recruiting now
• A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome — Recruiting now
• PrProfile: A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ION717 — Recruiting now
• A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) — Recruiting now
• A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy — Recruiting now
• A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC — Recruiting now
• FORWARD CAD IDE Study — Recruiting now
• Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors — Recruiting now
• This Study Will Evaluate the Effectiveness of NTX-001, a Surgical Nerve Repair Product When Used in People With Upper Extremity Nerve Lacerations. — Recruiting now
• Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF) — Recruiting now
• A Pivotal Study to Evaluate the Clinical Benefit, Performance and Safety of a Totally Implantable Cochlear Implant (TICI) System in Adults — Recruiting now
• Enhancing Engagement of Partners in Research — Recruiting now
• A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma — Recruiting now
• A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma — Recruiting now
• Effects of Belzutifan on 89Zr-DFO-girentuximab PET Uptake in Patients With Renal Cell Carcinoma (RCC) — Recruiting now
• A Study of Dotinurad Versus Allopurinol in Tophaceous Gout — Recruiting now
• A Study of Dotinurad Versus Allopurinol in Participants With Gout — Recruiting now
• Reducing AIR Pollution Exposure to Lower Blood PRESSURE Among New York City Public Housing Residents — Recruiting now
• Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01) — Recruiting now
• Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT) — Recruiting now
• GLP-1R Agonist Treatment for Opioid Use Disorder — Recruiting now
• A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer — Recruiting now
• TRYPTYR as a Treatment for Patients With Dry Eye Disease (DED) — Recruiting now
• PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort — Recruiting now
• CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis — Recruiting now
• Radiation After No Axillary Nodal Sampling — Recruiting now
• CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3) — Recruiting now
• An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid Tumors — Recruiting now
• Evaluation of Efficacy and Safety of THRV-1268 in Long QT Syndrome Type 2 (LQTS 2) — Recruiting now
• Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH) — Recruiting now
• A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies — Recruiting now
• Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma — Recruiting now
• Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers — Recruiting now